Skip to main content
. 2000 Nov;44(11):3118–3121. doi: 10.1128/aac.44.11.3118-3121.2000

TABLE 2.

Accumulation of antibiotics by Salmonella serovar Typhimurium isolates

Isolatea Resistance phenotype or genotypeb Accumulation (as ng of antibiotic/mg)c
Ciprofloxacin
Chloramphenicol
Tetracycline
−CCCP SD +CCCP −CCCP SD +CCCP −CCCP SD +CCCP
L3 Wild type 102.2 16.8 112.4 42.8 6.8 35.9 15.1 1.4 17.7
L5 MAR; gyrA 27.6 7.4 94.8 36.6 5.6 46.7 9.4 0.8 13.8
L6 MAR; dyes, detergents, hexane 61.3 8.3 102.7 23.9 1.6 45.2 7.3 1.9 13.3
L10 MAR; dyes, detergents, hexane 23.3 3.8 105.8 14.2 1.2 31.8 3.3 0.6 6.9
L12 MAR; dyes, detergents, hexane 47.4 7.8 44.3 27.4 6.9 26.5 4.9 1.5 8.8
L15 MAR; dyes, detergents 22.4 5.6 39.3 28.7 1.6 42.5 6.3 1.6 13.4
L18 MAR; acriflavine; gyrB 89.9 2.9 96.3 34.2 4.9 55.5 7.7 0.3 13.5
L19 Type strain (NCTC 74) 88.9 ND 38.1 39.3 9.5 9.9
T39 Parent strain ND ND 15.8 25.7 4.0 11.7
LX1054 acrB mutant ND ND 28.4 34.0 8.8 10.4
a

L3, pretherapy parent isolate; L5, L6, L10, L12, L15, and L18, posttherapy isolates. T39 (parent strain) and LX1054 (acrB mutant) were from Lacroix et al. (16). 

b

gyrA, Piddock et al. (26); gyrB, Gensberg et al. (9); MAR, 2- to 256-fold more resistant to quinolones and six or seven unrelated agents than L3. 

c

−CCCP, accumulation without CCCP; +CCCP, accumulation in the presence of CCCP; SD, standard deviation; ND, not done.